Martín-Varillas et al. ADA vs certolizumab in Cystoid Macular Edema in Behcets. “Equally” effective here but 80% of the certolizumab patients were previously refractory to ADA. @RheumNow #ACR22 Abstr#1567 https://t.co/ZKr38i2iA5 https://t.co/Jbtqlv9YAF